ADIM
XRAY icon

Alpha DNA Investment Management’s Dentsply Sirona XRAY Stock Holding History

Alpha DNA Investment Management’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22,030
Closed -$1.39M – 150
2021
Q2 		$1.39M Buy
+22,030
New +$1.45M 0.95% 68

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Alpha DNA Investment Management's XRAY Position: Q3 2021 in Review

Alpha DNA Investment Management sold out of Dentsply Sirona (XRAY) in Q3 2021, closing a stake of 22,030 shares — an estimated $1.39M sold.

Alpha DNA Investment Management first reported a position in XRAY in Q2 2021 and held it in 1 quarter. The position peaked at $1.39M in Q2 2021. 553 funds tracked by Wall St. Rank hold XRAY as of Q3 2021.

  • Alpha DNA Investment Management reported no remaining Dentsply Sirona position as of Q3 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 22,030 Dentsply Sirona shares in Q3 2021, an estimated $1.39M.
  • Alpha DNA Investment Management first reported a position in Dentsply Sirona in Q2 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Dentsply Sirona position peaked at $1.39M in Q2 2021.
  • 553 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2021.

Based on Alpha DNA Investment Management's 13F filing for Q3 2021, filed 10 Nov 2021.